Health disparities in patients with pulmonary arterial hypertension: A blueprint for action: An official American thoracic society statement

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 8, 2017, Pages e32-e47

  Talwar, Arunabh ^a   Garcia, Joe G N ^a   Tsai, Halley ^a   Moreno, Matthew ^a   Lahm, Tim ^a   Zamanian, Roham T ^a   Machado, Roberto ^a   Kawut, Steven M ^a   Selej, Mona ^a   Mathai, Stephen ^a   D'Anna, Laura Hoyt ^a   Sahni, Sonu ^a   Rodriquez, Erik J ^a   Channick, Richard ^a   Fagan, Karen ^a   Gray, Michael ^a   Armstrong, Jessica ^a   Lopez, Josanna Rodriguez ^a   De Jesus Perez, Vinicio ^a  

^a NONE

Author keywords

Genetics; Health disparities; Health policy; Pulmonary hypertension

Indexed keywords

AIR POLLUTION; ARTICLE; DIET; ENVIRONMENTAL STRESS; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; MEASUREMENT; MEDICAL EDUCATION; NUTRITION; PATIENT EDUCATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REGISTER; SOCIAL STATUS; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH CARE DISPARITY; HYPERTENSION, PULMONARY; INFANT; MALE; MEDICAL SOCIETY; MIDDLE AGED; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; STANDARDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH POLICY; HEALTHCARE DISPARITIES; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES; YOUNG ADULT;

EID: 85031693083     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201709-1821ST     Document Type: Article

References (131)

1. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349.
2. Galiè N, Humbert M, Vachiéry J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk-Noordegraaf A, Beghetti M, et al.; Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC); European Respiratory Society (ERS). 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015;46:903-975.
3. Wu W-H, Yang L, Peng F-H, Yao J, Zou L-L, Liu D, Jiang X, Li J, Gao L, Qu J-M, et al. Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med 2013;187:303-310.
4. Benza RL, Gomberg-Maitland M, Frost AE, Frantz RP, Humbert M, McGoon MD. Development of prognostic tools in pulmonary arterial hypertension: lessons from modern day registries. Thromb Haemost 2012;108:1049-1060.
5. McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev 2012;21:8-18.
6. Maron BA, Choudhary G, Khan UA, Jankowich MD, McChesney H, Ferrazzani SJ, Gaddam S, Sharma S, Opotowsky AR, Bhatt DL, et al. Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. Circ Heart Fail 2013;6:906-912.
7. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation 2016;133: 1240-1248.
8. Choudhary G, Jankowich M, Wu W-C. Prevalence and clinical characteristics associated with pulmonary hypertension in African- Americans. PLoS One 2013;8:e84264.
9. Davis KK, Lilienfeld DE, Doyle RL. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension. J Natl Med Assoc 2008;100:69-72.
10. Celedón JC, Roman J, Schraufnagel DE, Thomas A, Samet J. Respiratory health equality in the United States: the American Thoracic Society perspective. Ann Am Thorac Soc 2014;11:473-479.
11. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223.
12. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010;122:164-172.
13. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier J-F, Chabot F, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030.
14. Humbert M, Sitbon O, Yaïci A, Montani D, O'Callaghan DS, Jaïs X, Parent F, Savale L, Natali D, Günther S, et al.; French Pulmonary Arterial Hypertension Network. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36:549-555.
15. Jing Z-C, Xu X-Q, Han Z-Y, Wu Y, Deng K-W, Wang H, Wang Z-W, Cheng X-S, Xu B, Hu S-S, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007;132:373-379.
16. Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, Rosenzweig EB, Kerstein D, Barst RJ. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005;95:199-203.
17. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30:104-109.
18. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30:1103-1110.
19. Escribano-Subias P, Blanco I, López-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, Castillo-Palma MJ, Segovia J, Gómez- Sanchez MA, Barberà JA; REHAP Investigators. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 2012;40:596-603.
20. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, et al. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J 2012;39:945-955.
21. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier J-F, Chabot F, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156-163.
22. Hoeper MM, Huscher D, Ghofrani HA, DelcroixM, Distler O, Schweiger C, Grünig E, Staehler G, Rosenkranz S, Halank M, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA Registry. Int J Cardiol 2013;168:871-880.
23. Jacobs W, van de Veerdonk MC, Trip P, de Man F, Heymans MW, Marcus JT, Kawut SM, Bogaard HJ, Boonstra A, Vonk Noordegraaf A. The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension. Chest 2014;145:1230-1236.
24. Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest 2011;140:19-26.
25. Frantz RP, Barst RJ, Turner M, Watson P, McGoon MD. Regional heterogeneity in prostanoid utilization for pulmonary arterial hypertension in the United States [abstract]. Am J Respir Crit Care Med 2009;179:A3350.
26. McLaughlin VV, Langer A, Tan M, Clements PJ, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ; Pulmonary Arterial Hypertension-Quality Enhancement Research Initiative (PAH-QuERI) Investigators. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest 2013;143:324-332.
27. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156: 871-881.
28. Kawut SM, Lima JAC, Barr RG, Chahal H, Jain A, Tandri H, Praestgaard A, Bagiella E, Kizer JR, Johnson WC, et al. Sex and race differences in right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-right ventricle study. Circulation 2011;123: 2542-2551.
29. Ventetuolo CE, Ouyang P, Bluemke DA, Tandri H, Barr RG, Bagiella E, Cappola AR, Bristow MR, Johnson C, Kronmal RA, et al. Sex hormones are associated with right ventricular structure and function: the MESA-right ventricle study. Am J Respir Crit Care Med 2011;183:659-667.
30. Ventetuolo CE, Mitra N, Wan F, Manichaikul A, Barr RG, Johnson C, Bluemke DA, Lima JAC, Tandri H, Ouyang P, et al. Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function. Eur Respir J 2016;47:553-563.
31. Aaron CP, Chervona Y, Kawut SM, Diez Roux AV, Shen M, Bluemke DA, Van Hee VC, Kaufman JD, Barr RG. Particulate matter exposure and cardiopulmonary differences in the Multi-Ethnic Study of Atherosclerosis. Environ Health Perspect 2016;124: 1166-1173.
32. Leary PJ, Kaufman JD, Barr RG, Bluemke DA, Curl CL, Hough CL, Lima JA, Szpiro AA, Van Hee VC, Kawut SM. Traffic-related air pollution and the right ventricle: the Multi-Ethnic Study of Atherosclerosis. Am J Respir Crit Care Med 2014;189:1093-1100.
33. Lewandowski AJ, Augustine D, Lamata P, Davis EF, LazdamM, Francis J, McCormick K, Wilkinson AR, Singhal A, Lucas A, et al. Preterm heart in adult life: cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function. Circulation 2013;127:197-206.
34. Goss KN, Cucci AR, Fisher AJ, Albrecht M, Frump A, Tursunova R, Gao Y, Brown MB, Petrache I, Tepper RS, et al. Neonatal hyperoxic lung injury favorably alters adult right ventricular remodeling response to chronic hypoxia exposure. Am J Physiol Lung Cell Mol Physiol 2015; 308:L797-L806.
35. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67:737-744.
36. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA III, Loyd JE, Nichols WC, Trembath RC; International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-84.
37. Morse JH, Jones AC, Barst RJ, Hodge SE, Wilhelmsen KC, Nygaard TG. Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. Circulation 1997;95:2603-2606.
38. Nichols WC, Koller DL, Slovis B, Foroud T, Terry VH, Arnold ND, Siemieniak DR, Wheeler L, Phillips JA III, Newman JH, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 1997;15:277-280.
39. Marchuk DA. Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr Opin Hematol 1998;5:332-338.
40. Austin ED, Ma L, LeDuc C, Berman Rosenzweig E, Borczuk A, Phillips JA III, Palomero T, Sumazin P, Kim HR, Talati MH, et al. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet 2012;5:336-343.
41. Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët D-A, Borczuk A, Rosenzweig EB, et al. A novel channelopathy in pulmonary arterial hypertension. N Engl J Med 2013;369:351-361.
42. Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N, Coulet F, Bonnet D, Dorfmüller P, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet 2014;46:65-69.
43. Vadapalli S, Rani HS, Sastry B, Nallari P. Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertension. Int J Mol Epidemiol Genet 2010;1:208-213.
44. Calabrò P, Limongelli G, Maddaloni V, Vizza CD, D'Alto M, D'Alessandro R, Poscia R, Argiento P, Ziello B, Badagliacca R, et al. Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. Intern Emerg Med 2012;7:425-430.
45. Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang J-Y, et al. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation 2009;119:2313-2322.
46. Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA III. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009;34:1093-1099.
47. Damico R, Kolb TM, Valera L, Wang L, Housten T, Tedford RJ, Kass DA, Rafaels N, Gao L, Barnes KC, et al. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 2015;191:208-218.
48. Germain M, Eyries M, Montani D, Poirier O, Girerd B, Dorfmüller P, Coulet F, Nadaud S, Maugenre S, Guignabert C, et al. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet 2013;45:518-521.
49. Hemnes AR, Zhao M, West J, Newman JH, Rich S, Archer SL, Robbins IM, Blackwell TS, Cogan J, Loyd JE, et al. Critical genomic networks and vasoreactive variants in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2016;194:464-475.
50. Grigoryev DN, Mathai SC, Fisher MR, Girgis RE, Zaiman AL, Housten- Harris T, Cheadle C, Gao L, Hummers LK, Champion HC, et al. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res 2008;151:197-207.
51. Geraci MW. Integrating molecular genetics and systems approaches to pulmonary vascular diseases. Pulm Circ 2013;3:171-175.
52. Hoffmann J, Wilhelm J, Olschewski A, Kwapiszewska G. Microarray analysis in pulmonary hypertension. Eur Respir J 2016;48:229-241.
53. Austin ED, West J, Loyd JE, Hemnes AR. Translational advances in the field of pulmonary hypertension molecular medicine of pulmonary arterial hypertension: from population genetics to precision medicine and gene editing. Am J Respir Crit Care Med 2017;195:23-31.
54. Oh SS, Galanter J, Thakur N, Pino-Yanes M, Barcelo NE, White MJ, de Bruin DM, Greenblatt RM, Bibbins-Domingo K, Wu AHB, et al. Diversity in clinical and biomedical research: a promise yet to be fulfilled. PLoS Med 2015;12:e1001918.
55. Kangelaris KN, Sapru A, Calfee CS, Liu KD, Pawlikowska L, Witte JS, Vittinghoff E, Zhuo H, Auerbach AD, Ziv E, et al.; National Heart, Lung, and Blood Institute ARDS Network. The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury. Chest 2012;141:1160-1169.
56. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006;34:487-495.
57. Christie JD, Ma SF, Aplenc R, Li M, Lanken PN, Shah CV, Fuchs B, Albelda SM, Flores C, Garcia JGN. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit Care Med 2008;36:2794-2800.
58. Flores C, Ma SF, Maresso K, Ober C, Garcia JGN. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet Epidemiol 2007;31:296-305.
59. Ma SF, Flores C, Wade MS, Dudek SM, Nicolae DL, Ober C, Garcia JGN. A common cortactin gene variation confers differential susceptibility to severe asthma. Genet Epidemiol 2008; 32:757-766.
60. Sun X, Ma SF, Wade MS, Flores C, Pino-Yanes M, Moitra J, Ober C, Kittles R, Husain AN, Ford JG, et al. Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibility. J Allergy Clin Immunol 2010;126:241-249, 249. e1-249.e3.
61. Flores C, Ma SF, Pino-Yanes M, Wade MS, Pérez-Méndez L, Kittles RA, Wang D, Papaiahgari S, Ford JG, Kumar R, et al. African ancestry is associated with asthma risk in African Americans. PLoS One 2012;7: e26807.
62. Galanter JM, Gignoux CR, Torgerson DG, Roth LA, Eng C, Oh SS, Nguyen EA, Drake KA, Huntsman S, Hu D, et al. Genome-wide association study and admixture mapping identify different asthmaassociated loci in Latinos: the Genes-environments & Admixture in Latino Americans study. J Allergy Clin Immunol 2014;134:295-305.
63. Seibold MA, Wang B, Eng C, Kumar G, Beckman KB, Sen S, Choudhry S, Meade K, Lenoir M, Watson HG, et al. An African-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. Hum Mol Genet 2008;17: 2681-2690.
64. Chen W, Brehm JM, Manichaikul A, Cho MH, Boutaoui N, Yan Q, Burkart KM, Enright PL, Rotter JI, Petersen H, et al. A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. Ann Am Thorac Soc 2015;12:340-348.
65. Pino-Yanes M, Thakur N, Gignoux CR, Galanter JM, Roth LA, Eng C, Nishimura KK, Oh SS, Vora H, Huntsman S, et al. Genetic ancestry influences asthma susceptibility and lung function among Latinos. J Allergy Clin Immunol 2015;135:228-235.
66. Chen W, Boutaoui N, Brehm JM, Han Y-Y, Schmitz C, Cressley A, Acosta-Pérez E, Alvarez M, Colón-Semidey A, Baccarelli AA, et al. ADCYAP1R1 and asthma in Puerto Rican children. Am J Respir Crit Care Med 2013;187:584-588.
67. Torgerson DG, Capurso D, Ampleford EJ, Li X, Moore WC, Gignoux CR, Hu D, Eng C, Mathias RA, Busse WW, et al. Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects. J Allergy Clin Immunol 2012;130:622-629.e9.
68. Drake KA, Torgerson DG, Gignoux CR, Galanter JM, Roth LA, Huntsman S, Eng C, Oh SS, Yee SW, Lin L, et al. A genome-wide association study of bronchodilator response in Latinos implicates rare variants. J Allergy Clin Immunol 2014;133:370-378.
69. Igartua C, Myers RA, Mathias RA, Pino-Yanes M, Eng C, Graves PE, Levin AM, Del-Rio-Navarro BE, Jackson DJ, Livne OE, et al. Ethnicspecific associations of rare and low-frequency DNA sequence variants with asthma. Nat Commun 2015;6:5965.
70. Vergara C, Murray T, Rafaels N, Lewis R, Campbell M, Foster C, Gao L, Faruque M, Oliveira RR, Carvalho E, et al. African ancestry is a risk factor for asthma and high total IgE levels in African admixed populations. Genet Epidemiol 2013;37:393-401.
71. Corvol H, De Giacomo A, Eng C, Seibold M, Ziv E, Chapela R, Rodríguez-Santana JR, Rodríguez-Cintrón W, Thyne S, Watson HG, et al.; Genetics of Asthma in Latino Americans (GALA) Study; Study of African-Americans, Asthma, Genes and Environments (SAGE) Investigators. Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma. Pharmacogenet Genomics 2009; 19:489-496.
72. Burchard EG, Avila PC, Nazario S, Casal J, Torres A, Rodríguez- Santana JR, Toscano M, Sylvia JS, Alioto M, Salazar M, et al.; Genetics of Asthma in Latino Americans (GALA) Study. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med 2004;169:386-392.
73. Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, Torres A, Gorman JD, Salari K, Rodríguez-Santana JR, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005;171: 563-570.
74. Salari K, Burchard EG. Latino populations: a unique opportunity for epidemiological research of asthma. Paediatr Perinat Epidemiol 2007;21:15-22.
75. Krieger N. A glossary for social epidemiology. J Epidemiol Community Health 2001;55:693-700.
76. Kington RS, Smith JP. Socioeconomic status and racial and ethnic differences in functional status associated with chronic diseases. Am J Public Health 1997;87:805-810.
77. AdlerNE, Boyce T, ChesneyMA, CohenS, Folkman S, Kahn RL, SymeSL. Socioeconomic status and health: the challenge of the gradient. Am Psychol 1994;49:15-24.
78. Feinstein JS. The relationship between socioeconomic status and health: a review of the literature. Milbank Q 1993;71:279-322.
79. Chetty R, Stepner M, Abraham S, Lin S, Scuderi B, Turner N, Bergeron A, Cutler D. The association between income and life expectancy in the United States, 2001-2014. JAMA 2016;315:1750-1766.
80. Shavers VL. Measurement of socioeconomic status in health disparities research. J Natl Med Assoc 2007;99:1013-1023.
81. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S. Socioeconomic status in health research: one size does not fit all. JAMA 2005;294:2879-2888.
82. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137:376-387.
83. Talwar A, Sahni S, Talwar A, Kohn N, Klinger JR. Socioeconomic status affects pulmonary hypertension disease severity at time of first evaluation. Pulm Circ 2016;6:191-195.
84. Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999;341:1359-1367.
85. Ver Ploeg M, Perrin E, editors; National Research Council; Committee on National Statistics, Division of Behavioral and Social Sciences and Education. Eliminating health disparities: measurement and data needs [panel on DHHS Collection of Race and Ethnicity Data]. Washington, DC: National Academies Press; 2004.
86. Studer SM. Should providers routinely "prescribe" support group participation for their patients with PAH? Adv PH J 2014;13:146-147.
87. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez- Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, et al.; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010;121:2331-2378.
88. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260.
89. Gold DR, Samet JM. Air pollution, climate, and heart disease. Circulation 2013;128:e411-e414.
90. Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:1753-1759.
91. Münzel T, Sørensen M, Gori T, Schmidt FP, Rao X, Brook FR, Chen LC, Brook RD, Rajagopalan S. Environmental stressors and cardiometabolic disease: part II-mechanistic insights. Eur Heart J 2017; 38:557-564.
92. Franchini M, Mannucci PM. Thrombogenicity and cardiovascular effects of ambient air pollution. Blood 2011;118:2405-2412.
93. Bonzini M, Tripodi A, Artoni A, Tarantini L, Marinelli B, Bertazzi PA, Apostoli P, Baccarelli A. Effects of inhalable particulate matter on blood coagulation. J Thromb Haemost 2010;8:662-668.
94. Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. Circ Res 2015;116:1680-1690.
95. Robinson JC, Graham BB, Rouault TC, Tuder RM. The crossroads of iron with hypoxia and cellular metabolism: implications in the pathobiology of pulmonary hypertension. Am J Respir Cell Mol Biol 2014;51:721-729.
96. Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JSR, Wharton J, Wilkins MR. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol 2011;58: 300-309.
97. Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 2011;37:1386-1391.
98. Howard LSGE, Watson GMJ, Wharton J, Rhodes CJ, Chan K, Khengar R, Robbins PA, Kiely DG, Condliffe R, Elliott CA, et al. Supplementation of iron in pulmonary hypertension: rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension. Pulm Circ 2013;3:100-107.
99. Welch M. Required curricula in diversity and cross-cultural medicine: the time is now. J Am Med Womens Assoc 1998;53(3 Suppl): 121-123, 130.
100. Flores G. Culture and the patient-physician relationship: achieving cultural competency in health care. J Pediatr 2000;136:14-23.
101. Betancourt JR, Carrillo JE, Green AR. Hypertension in multicultural and minority populations: linking communication to compliance. Curr Hypertens Rep 1999;1:482-488.
102. Stewart M, Brown JB, Boon H, Galajda J, Meredith L, Sangster M. Evidence on patient-doctor communication. Cancer Prev Control 1999;3:25-30.
103. Morales LS, Cunningham WE, Brown JA, Liu H, Hays RD. Are Latinos less satisfied with communication by health care providers? J Gen Intern Med 1999;14:409-417.
104. Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, Ford DE. Race, gender, and partnership in the patient-physician relationship. JAMA 1999;282:583-589.
105. Langer N. Culturally competent professionals in therapeutic alliances enhance patient compliance. J Health Care Poor Underserved 1999;10:19-26.
106. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dubé R, Taleghani CK, Burke JE, Williams S, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999;340:618-626.
107. Sabin JA, Greenwald AG. The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma. Am J Public Health 2012;102:988-995.
108. Kline JA, Russell FM, Lahm T, Mastouri RA. Derivation of a screening tool to identify patients with right ventricular dysfunction or tricuspid regurgitation after negative computerized tomographic pulmonary angiography of the chest. Pulm Circ 2015;5:171-183.
109. Russell FM, Moore CL, Courtney DM, Kabrhel C, Smithline HA, Nordenholz KE, Richman PB, O'Neil BJ, Plewa MC, Beam DM, et al. Independent evaluation of a simple clinical prediction rule to identify right ventricular dysfunction in patients with shortness of breath. Am J Emerg Med 2015;33:542-547.
110. Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani H-A, Hoeper MM, Lang IM, Preiss R, et al.; GRIPHON Investigators. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med 2015;373:2522-2533.
111. Galiè N, Barberà JA, Frost AE, Ghofrani H-A, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiéry J-L, Grünig E, et al.; AMBITION Investigators. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015;373:834-844.
112. Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Jing Z-C, Le Brun F-O, Mehta S, et al.; SERAPHIN Investigators. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 2013;369:809-818.
113. Eisenberg JM. Sociologic influences on decision-making by clinicians. Ann Intern Med 1979;90:957-964.
114. Carrillo JE, Green AR, Betancourt JR. Cross-cultural primary care: a patient-based approach. Ann Intern Med 1999;130:829-834.
115. Awosogba T, Betancourt JR, Conyers FG, Estapé ES, Francois F, Gard SJ, Kaufman A, Lunn MR, Nivet MA, Oppenheim JD, et al. Prioritizing health disparities in medical education to improve care. Ann N Y Acad Sci 2013;1287:17-30.
116. Culhane-Pera KA, Reif C, Egli E, Baker NJ, Kassekert R. A curriculum for multicultural education in family medicine. Fam Med 1997;29: 719-723.
117. Zweifler J, Gonzalez AM. Teaching residents to care for culturally diverse populations. Acad Med 1998;73:1056-1061.
118. VanderWielen LM, Vanderbilt AA, Crossman SH, Mayer SD, Enurah AS, Gordon SS, Bradner MK. Health disparities and underserved populations: a potential solution, medical school partnerships with free clinics to improve curriculum. Med Educ Online 2015;20:27535.
119. Miranda J, Duan N, Sherbourne C, Schoenbaum M, Lagomasino I, Jackson-Triche M, Wells KB. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. Health Serv Res 2003;38:613-630.
120. Einbinder LC, Schulman KA. The effect of race on the referral process for invasive cardiac procedures. Med Care Res Rev 2000;57: 162-180.
121. Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc 2002;94:666-668.
122. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. The predictors of patient-physician race and ethnic concordance: a medical facility fixed-effects approach. Health Serv Res 2010;45: 792-805.
123. Powe NR, Cooper LA. Disparities in patient experiences, health care processes, and outcomes: the role of patient-provider racial, ethnic, and language concordance. New York: Commonwealth Fund; 2004 [accessed 2017 Aug 25]. Available from: http://www. commonwealthfund.org/publications/fund-reports/2004/jul/disparitiesin- patient-experiences-health-care-processes-and-outcomes-therole-of-patient-provide
124. Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. "We don't carry that"-failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 2000;342: 1023-1026.
125. Silva MD, Genoff M, Zaballa A, Jewell S, Stabler S, Gany FM, Diamond LC. Interpreting at the end of life: a systematic review of the impact of interpreters on the delivery of palliative care services to cancer patients with limited English proficiency. J Pain Symptom Manage 2016;51:569-580.
126. Karliner LS, Jacobs EA, Chen AH, Mutha S. Do professional interpreters improve clinical care for patients with limited English proficiency? A systematic review of the literature. Health Serv Res 2007;42:727-754.
127. U.S. Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation and Office of Minority Health. HHS Action Plan to Reduce Racial and Ethnic Health Disparities: Implementation Progress Report 2011-2014. Washington, DC: Office of the Assistant Secretary for Planning and Evaluation; 2015 [accessed 2017 Aug 25]. Available from: https://minorityhealth.hhs.gov/assets/pdf/FINAL-HHS-Action-Plan-Progress-Report-11-2-2015.pdf
128. Smedley BD, Stith AY, Nelson AR; Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press; 2003.
129. National Institute on Minority Health and Health Disparities. About NIMHD [accessed 2017 Aug 25]. Available from: https://www.nimhd.nih.gov/about/
130. Office of Public Affairs, Federation of American Societies for Experimental Biology. NIH research funding rebounds in president's FY 2016 budget [accessed 2017 Aug 25]. Available from: https://www.faseb.org/Portals/2/PDFs/opa/2015/2.10.15%20NIH%20Funding%20Cuts%202-pager.pdf
131. Sahni S, Talwar A, Khanijo S, Talwar A. Socioeconomic status and its relationship to chronic respiratory disease. Adv Respir Med 2017; 85:97-108.